Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

NCT02218177 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: Aflibercept
DRUG: Ranibizumab
PROCEDURE: Combination Photodynamic Therapy

Sponsor

University Health Network, Toronto